X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare GSK Consumer with KAVERI SEED - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK CONSUMER vs KAVERI SEED - Comparison Results

GSK CONSUMER    Change

GSK Consumer dominates the Rs 26 bn Indian malted beverage market with a significant 70% share (in volume terms). Its white beverage brand 'Horlicks' pioneered the broadening of the malted beverage market in India. Horlicks alone, as a white beverage... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK CONSUMER KAVERI SEED GSK CONSUMER/
KAVERI SEED
 
P/E (TTM) x 34.3 26.6 129.2% View Chart
P/BV x 9.2 4.0 228.4% View Chart
Dividend Yield % 1.3 0.5 277.5%  

Financials

 GSK CONSUMER   KAVERI SEED
EQUITY SHARE DATA
    GSK CONSUMER
Mar-16
KAVERI SEED
Mar-16
GSK CONSUMER/
KAVERI SEED
5-Yr Chart
Click to enlarge
High Rs6,7711,060 638.7%   
Low Rs5,448300 1,816.0%   
Sales per share (Unadj.) Rs1,024.4129.3 792.4%  
Earnings per share (Unadj.) Rs163.325.0 653.2%  
Cash flow per share (Unadj.) Rs177.029.0 610.9%  
Dividends per share (Unadj.) Rs70.002.50 2,800.0%  
Dividend yield (eoy) %1.10.4 311.7%  
Book value per share (Unadj.) Rs581.5131.3 442.9%  
Shares outstanding (eoy) m42.0669.06 60.9%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x6.05.3 113.4%   
Avg P/E ratio x37.427.2 137.6%  
P/CF ratio (eoy) x34.523.5 147.1%  
Price / Book Value ratio x10.55.2 202.9%  
Dividend payout %42.910.0 428.7%   
Avg Mkt Cap Rs m256,95946,961 547.2%   
No. of employees `0003.70.8 482.7%   
Total wages/salary Rs m5,094388 1,314.6%   
Avg. sales/employee Rs Th11,548.511,549.5 100.0%   
Avg. wages/employee Rs Th1,365.3501.3 272.4%   
Avg. net profit/employee Rs Th1,841.12,233.9 82.4%   
INCOME DATA
Net Sales Rs m43,0878,928 482.6%  
Other income Rs m2,788174 1,602.9%   
Total revenues Rs m45,8759,102 504.0%   
Gross profit Rs m8,3491,886 442.6%  
Depreciation Rs m574274 209.7%   
Interest Rs m82 329.2%   
Profit before tax Rs m10,5541,784 591.7%   
Minority Interest Rs m04 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,68561 6,050.6%   
Profit after tax Rs m6,8691,727 397.8%  
Gross profit margin %19.421.1 91.7%  
Effective tax rate %34.93.4 1,022.6%   
Net profit margin %15.919.3 82.4%  
BALANCE SHEET DATA
Current assets Rs m37,56010,936 343.5%   
Current liabilities Rs m18,1534,035 449.9%   
Net working cap to sales %45.077.3 58.3%  
Current ratio x2.12.7 76.3%  
Inventory Days Days39206 19.0%  
Debtors Days Days3033 91.3%  
Net fixed assets Rs m5,3742,209 243.2%   
Share capital Rs m421138 304.6%   
"Free" reserves Rs m24,0038,929 268.8%   
Net worth Rs m24,4569,067 269.7%   
Long term debt Rs m016 0.0%   
Total assets Rs m44,98813,186 341.2%  
Interest coverage x1,336.9744.2 179.6%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.00.7 141.5%   
Return on assets %15.313.1 116.6%  
Return on equity %28.119.0 147.5%  
Return on capital %43.219.7 219.1%  
Exports to sales %5.11.1 460.8%   
Imports to sales %0.40-   
Exports (fob) Rs m2,21199 2,223.9%   
Imports (cif) Rs m168NA-   
Fx inflow Rs m2,81699 2,832.9%   
Fx outflow Rs m2616 4,071.1%   
Net fx Rs m2,55593 2,747.7%   
CASH FLOW
From Operations Rs m5,7242,255 253.8%  
From Investments Rs m-1,569-2,018 77.7%  
From Financial Activity Rs m-2,792-208 1,342.9%  
Net Cashflow Rs m1,36329 4,651.5%  

Share Holding

Indian Promoters % 0.0 57.6 -  
Foreign collaborators % 72.5 0.0 -  
Indian inst/Mut Fund % 0.8 9.3 8.6%  
FIIs % 12.0 18.9 63.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 14.8 14.1 105.0%  
Shareholders   26,457 12,876 205.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK CONSUMER With:   BRITANNIA  RUCHI SOYA INDUSTRIES  LAKSHMI OVERSEAS IND.  AVANTI FEEDS  SAVITA OIL TECH.  

Compare GSK CONSUMER With:   TIGER BRANDS (S. Africa)  COCA COLA (US)  NESTLE (Switz.)  AVI LTD. (S. Africa)  



Today's Market

Sensex Finishes on a Flat Note; Dr Reddy's & Lupin Surge over 2%(Closing)

Indian share markets continued to trade just above the dotted line in the afternoon session in a lackluster day of trading. At the closing bell, the BSE Sensex closed higher by 33 points.

Related Views on News

GSK Consumer: On the Recovery Path (Quarterly Results Update - Detailed)

Jun 20, 2017

While GSK consumer reported muted revenue growth, volumes are seen to be recovering.

GSK Consumer: Price Hike Hurts Volumes (Quarterly Results Update - Detailed)

Nov 30, 2016

GSK Consumer Healthcare declared results for the quarter ended September 2016. The revenues dropped by 1.3% during the quarter as compared to a year ago; while the profits declined by 16.6% YoY during the quarter.

Apex frozen food Ltd. (IPO)

Aug 21, 2017

Should you subscribe to the IPO of Apex Frozen Foods Ltd?

ITC: Demonetisation woes pull down business growth (Quarterly Results Update - Detailed)

Feb 8, 2017

ITC Ltd has announced third quarter results of the financial year 2016-2017 (3QFY17). The company has reported 4.7% YoY and 5.7% YoY growth in revenues and net profits respectively. Here is our analysis of the results.

ITC: A Decent Quarter Amidst Challenging Environment (Quarterly Results Update - Detailed)

Dec 7, 2016

ITC has announced second quarter results of the financial year 2016-2017 (2QFY17). The company has reported 8% YoY and 10.5% YoY growth in revenues and net profits respectively.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GSK CONSUMER SHARE PRICE


Aug 22, 2017 (Close)

TRACK GSK CONSUMER

  • Track your investment in GSK CONSUMER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK CONSUMER 5-YR ANALYSIS

COMPARE GSK CONSUMER WITH

MARKET STATS